Peninsula Regional Brings Advanced Radiation Therapy Technology to Delmarva Patients
The Richard A. Henson Cancer Institute at Peninsula Regional Medical Center in Salisbury, Maryland, has added new technology that will make its radiation therapy treatments more precise and protective of healthy tissue.
RapidArc® radiotherapy treatment is being launched at the Henson Cancer Institute on January 30. The helical intensity modulated treatment technology used by RapidArc provides superior protection to critical structures including the spinal cord, brainstem, eyes, optic nerve and chiasm, parotid glands and brain, and provides a much faster treatment time for Radiation Oncology patients. Even complex RapidArc treatment plans can be delivered in less than two minutes, which is up to 8 times faster than traditional IMRT treatment. The new system will allow radiation oncologists at the Henson Cancer Institute to serve their patients with the best, most up-to-date treatments available.
RapidArc rotates 360 degrees around the patient, aiming a precise treatment beam that continually shifts to match the shape and size of the tumor at every angle. Unlike some other forms of radiation therapy, with RapidArc, the radiation can be modulated continuously throughout the treatment. This means that higher doses of radiation are able to hit the tumor harder, while less radiation is delivered to healthy tissue. The precision in dosage and sparing of healthy tissue reduces treatment side effects and improves clinical outcomes for patients.
“We are pleased to be able to serve our patients with this advanced technology,” said Matthew Snyder, MD, Medical Director of the Radiation Oncology Department at Peninsula Regional. “Our first priority is offering Delmarva residents who have cancer compassionate, comprehensive care, close to home. RapidArc technology represents another step toward that mission.”